Internal Medicine, Hematology & Oncology · Babylon, NY
NPI
1376727941
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
72 E Main St Ste 1
Babylon, NY, 11702
Phone (631) 751-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.4M
125,139 services
Medicare patients, 2024
1,011
Average age 75
Drug cost, 2024
$4.6M
1,037 prescriptions
Company payments, 2025
$12K
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Richard M Zuniga was code J1439 (injection, ferric carboxymaltose, 1 mg), 48,000 times for 45 patients. In total Richard M Zuniga billed 125,139 services in 187 codes, and Medicare paid $1.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-06-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 48,000 | 45 | $0.87 | $42K |
| J1756 Injection, iron sucrose, 1 mg | Office | 15,000 | 41 | $0.18 | $2,664 |
| 88185 Surgical Pathology Examination | Office | 2,117 | 83 | $22.03 | $47K |
| 36415 Venipuncture Blood Collection | Office | 1,702 | 557 | $8.64 | $15K |
| 85025 Blood Count | Office | 1,688 | 549 | $7.59 | $13K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,481 | 47 | $0.09 | $130 |
| 80053 Clinical Chemistry | Office | 1,119 | 467 | $10.32 | $12K |
| 99233 Hospital E&M - Subsequent | Facility | 1,088 | 427 | $104.97 | $114K |
| 82728 Clinical Chemistry | Office | 754 | 368 | $13.33 | $10K |
| 83540 Clinical Chemistry | Office | 746 | 363 | $6.32 | $4,718 |
| 83550 Clinical Chemistry | Office | 742 | 362 | $8.54 | $6,337 |
| 84100 Clinical Chemistry | Office | 688 | 344 | $4.63 | $3,186 |
| 83615 Clinical Chemistry | Office | 657 | 318 | $5.91 | $3,884 |
| 83735 Clinical Chemistry | Office | 656 | 313 | $6.55 | $4,297 |
| 99214 Office E&M - Established | Office | 633 | 312 | $105.75 | $67K |
By year: 2022 $1.5M for 127,236 services; 2023 $868K for 109,636 services; 2024 $1.4M for 125,139 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88185 Surgical Pathology Examination | 2,117 | 83 | $22.03 | $47K |
| 36415 Venipuncture Blood Collection | 1,702 | 557 | $8.64 | $15K |
| 85025 Blood Count | 1,688 | 549 | $7.59 | $13K |
| 80053 Clinical Chemistry | 1,119 | 467 | $10.32 | $12K |
| 82728 Clinical Chemistry | 754 | 368 | $13.33 | $10K |
| 83540 Clinical Chemistry | 746 | 363 | $6.32 | $4,718 |
| 83550 Clinical Chemistry | 742 | 362 | $8.54 | $6,337 |
| 84100 Clinical Chemistry | 688 | 344 | $4.63 | $3,186 |
| 83615 Clinical Chemistry | 657 | 318 | $5.91 | $3,884 |
| 83735 Clinical Chemistry | 656 | 313 | $6.55 | $4,297 |
Medicare prescription drug claims, 2024
In 2024, the drug Richard M Zuniga prescribed most often to Medicare patients was Aranesp (Darbepoetin Alfa In Polysorbat), with 91 prescriptions and refills. In total Richard M Zuniga wrote 1,037 Medicare prescriptions that cost $4.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Aranesp Darbepoetin Alfa In Polysorbat | 91 | 93 | 21 | $276K |
| Anastrozole Generic | 58 | 108 | 15 | $728 |
| Procrit Epoetin Alfa | 44 | 44 | Under 11 | $107K |
| Akynzeo Fosnetupitant/Palonosetron | 44 | 44 | Under 11 | $37K |
| Dexamethasone Generic | 34 | 36 | Under 11 | $521 |
| Eliquis Apixaban | 30 | 48 | Under 11 | $26K |
| Prednisone Generic | 29 | 31 | Under 11 | $157 |
| Warfarin Sodium Generic | 29 | 43 | Under 11 | $184 |
| Xarelto Rivaroxaban | 27 | 31 | Under 11 | $17K |
| Hydroxyurea Generic | 22 | 47 | Under 11 | $475 |
| Abiraterone Acetate Generic | 22 | 22 | Under 11 | $53K |
| Acyclovir Generic | 21 | 21 | Under 11 | $191 |
| Ondansetron Odt Ondansetron | 21 | 22 | 17 | $297 |
| Xgeva Denosumab | 20 | 20 | Under 11 | $63K |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 19 | 19 | Under 11 | $272K |
Brand drugs: 605 claims; generic drugs: 432 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Richard M Zuniga $12K ($1,344 in general payments such as food, travel and fees and $11K for research) from 29 companies. The largest payer was F. Hoffmann-La Roche AG with $9,964.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.